Mark, P. , Dekkers, I., Blankestijn, P., Leiner, T. and Roditi, G. (2018) Letter on 'European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis'. Journal of the European Academy of Dermatology and Venereology, 32(2), e84-e85. (doi: 10.1111/jdv.14774) (PMID:29283443)
|
Text
154356.pdf - Accepted Version 226kB |
Abstract
We read with interest the guidelines recently published on sclerosing diseases of the skin (Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis)[1, 2]. However, we are concerned that the guideline recommendations proposed for prevention of nephrogenic systemic fibrosis (NSF) are potentially dangerous. Although we recognise the challenges in constructing comprehensive guidelines, we are concerned that this may be because the guidelines have not involved a multidisciplinary team.
Item Type: | Articles (Letter) |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Roditi, Dr Giles and Mark, Professor Patrick |
Authors: | Mark, P., Dekkers, I., Blankestijn, P., Leiner, T., and Roditi, G. |
Subjects: | R Medicine > RC Internal medicine |
College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing |
Journal Name: | Journal of the European Academy of Dermatology and Venereology |
Publisher: | Wiley |
ISSN: | 0926-9959 |
ISSN (Online): | 1468-3083 |
Published Online: | 28 December 2017 |
Copyright Holders: | Copyright © 2017 European Academy of Dermatology and Venereology |
First Published: | First published in Journal of the European Academy of Dermatology and Venereology 32(2): e84-e85 |
Publisher Policy: | Reproduced in accordance with the copyright policy of the publisher |
University Staff: Request a correction | Enlighten Editors: Update this record